Gliptagreat M 1000 Tablet is an anti-diabetic medication that combines Vildagliptin (a DPP-4 inhibitor) with Metformin (a biguanide). Previously, type 2 diabetes mellitus was referred to as “maturity-onset diabetes” or “non-insulin-dependent diabetes mellitus (NIDDM).” If the body does not create enough insulin or if the insulin it does produce does not function as it should, type 2 diabetes will develop. It may also appear if the body overproduces glucagon. One chemical that helps lower blood sugar levels is insulin, particularly after meals. Another drug that causes the liver to produce more sugar is Gliptagreat M 1000 Tablet, which raises blood sugar levels. Both of these chemicals are produced by the pancreas.
The Gliptagreat M 1000 Tablet aids with blood sugar regulation. It functions by causing the pancreas to produce less glucagon and more insulin (vildagliptin effect), as well as by assisting the body in using the insulin it already has more effectively (metformin impact). During Gliptagreat M 1000 Tablet treatment, you must continue to adhere to the prescribed diet and exercise regimen. Gliptagreat M 1000 Tablet is not an insulin replacement. Diabetic ketoacidosis and type 1 diabetes, in which the body does not make insulin, are not treated with it.
To prevent an upset stomach, Gliptagreat M 1000 Tablets should be taken with food. For optimal effects, Gliptagreat M 1000 Tablets should be taken consistently at the same time of day. Your doctor will determine the appropriate dosage for you based on your condition, which can change rapidly. Hypoglycemia, or low blood glucose, is the most frequent side effect of Gliptagreat M 1000 Tablet. It is marked by symptoms such as dry mouth and skin, palpitations, sweating, and dizziness. Therefore, you should not skip meals and should always have some kind of sugar on hand to prevent hypoglycemia. Changes in taste, nausea, diarrhoea, headaches, stomachaches, and upper respiratory problems are additional adverse effects.
The Gliptagreat M 1000 Tablet reduces the excess sugar produced by your liver, increases the amount of insulin produced by your pancreas, and helps you use insulin efficiently. It aids in regulating how quickly your body’s blood sugar levels rise after eating. In addition to preventing major consequences of diabetes such as kidney disease (nephropathy), nerve damage (neuropathy), diabetic foot ulcers, and delayed wound healing, Gliptagreat M 1000 Tablet is essential for blood sugar regulation.
Patients with type 1 diabetes or diabetic ketoacidosis should not use Gliptagreat M 1000 Tablet. While taking Gliptagreat M 1000 Tablet, some diabetic individuals may get lactic acidosis, an uncommon but dangerous illness. This condition causes an excess of lactic acid to build up in the blood, which can harm the function of the kidneys and liver, which are responsible for removing excess lactic acid from the blood. Inform your doctor if you have ever experienced kidney illness, low vitamin B12 levels, or pancreatitis (inflammation of the pancreas) before beginning to take Gliptagreat M 1000 Tablet. When used with insulin, Gliptagreat M 1000 Tablet may drastically drop blood sugar levels, resulting in hypoglycemia, a potentially dangerous disease. In this situation, your doctor might reduce the dosage of Gliptagreat M 1000 Tablet or insulin. It is advised to have your thyroid-stimulating hormone (TSH) checked annually because long-term use of Gliptagreat M 1000 Tablet may cause your TSH levels to drop. Rarely, you can also get bullous pemphigoid, a severe skin response that needs to be treated right away. If you anticipate receiving an injection of a dye or X-ray contrast agent during a diagnostic test, let your doctor know. Before undergoing an X-ray procedure, the Gliptagreat M 1000 Tablet should be stopped for a brief period of time.
In Stock
Reviews
There are no reviews yet.